30
Oct
Sanofi Consumer Health care India Limited (BSE: 544250; NSE: SANOFICONR) reported a 12% year-on-year increase in revenue to ₹2,631 million for the third quarter of 2026, supported by 19% growth in domestic sales and improved performance across key brands. The company’s profit before tax rose 22% year-on-year to ₹1,027 million, while earnings per share (EPS) increased by ₹5.95, representing a 22% growth. Managing Director Himanshu Bakshi said the performance reflected disciplined strategy execution, volume expansion and market share gains across key brands. He added that investments in brand building, distribution expansion and engagement with health care professionals were helping the…
